| |
|
Clinical Studies |
| |
|
|
| |
|
|
SCOPE OF ACTIVITY |
| |
|
|
|
|
| |
|
|
|
The studies are undertaken with competent Principle Investigators at the desired institutes in India at all major centres. The Clinical studies of Phase II/III/IV and promotional nature studies are undertaken in a GCP compliant manner. We also undertake the drug experience report on various products |
| |
|
|
|
|
|
| |
|
|
|
|
1. Protocol design with biometric support
2. IRB/EC documentation
3. Regulatory submissions
4. CT registration to national authorities
5. Conduct of the study
6. Compilation of CRF
7. Analysis of results and conclusion
8. Final report writing |
|
| |
| |
|
|
| |
|
International Strategic Partners |
| |
|
|
|
|
|
| |
|
|
U.K.
Dr. NAEEM KHAN
Consultant Pharmaceuticals and Allied Industries,
U.S.A
Mr. JURIJ PETRIN,
MD President and CEO
Pharmaceutical Regulatory Services, Inc. |
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
 |
|
|
| |
| |
|
Contact Us |
| |
|
| |
|
|
| |
|
|
| |
|
|
|
|
| |
|
 |
Director’s Blog |
|
| |
|
Discussion Of Past Events, Current Issues And What The Future May Look Like In The Healthcare Industry And Medical Education |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
